For example, high-dose vitamin C exhibits anticancer effect in KRAS- and BRAF-mutant colorectal cancer (CRC) cells by promoting ROS accumulation, inducing the S-glutathionylation of GAPDH at Cys152, and inhibiting glycolysis [130]. This evidence concerns the gene BRAF and colorectal carcinoma.